Table 2.
Summary of association between reported doses and campaigns, based on NP-AFP data between January 2010 and July 2015, by WHO region.
| Region | NP-AFP cases | Under-immunized cases | Zero-dose cases | SIA effect on Average Dose (Model 1) |
SIA effect on Under-Immunized Fraction (Model 2) |
SIA effect on Zero-Dose Fraction (Model 3) |
|||
|---|---|---|---|---|---|---|---|---|---|
| Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | ||||
| AFR | 41,179 | 7790 | 1650 | 0.15 | (0.13, 0.17) | 0.13 | (0.10, 0.16) | 0.09 | (0.02, 0.15) |
| EMR | 16,904 | 1620 | 644 | 0.45 | (0.43, 0.47) | 0.21 | (0.19, 0.22) | 0.20 | (0.16, 0.23) |
| SEAR | 73,262 | 3444 | 647 | 0.65 | (0.62, 0.68) | 0.44 | (0.33, 0.53) | 0.78 | (0.65, 0.86) |